Neil Gallagher M.D.

Neil Gallagher MD PhD is an experienced leader in the pharmaceutical and biotechnology sectors, currently serving as a Non Executive Director at iOnctura, Foghorn Therapeutics Inc., and Zymeworks Inc., while also advising the board and chairing the R&D Committee at Nouscom. Previously, Neil contributed to Syndax Pharmaceuticals as President of Research & Development and held high-level positions at AbbVie, Amgen, and Novartis, including roles as Head of Global Oncology Development and Sr Vice President, Development. Neil's educational background includes an MD from Trinity College Dublin and a PhD in Cancer Biology from the University of Birmingham.